atect Past Earnings Performance
Past criteria checks 2/6
atect has been growing earnings at an average annual rate of 15%, while the Life Sciences industry saw earnings growing at 28.2% annually. Revenues have been growing at an average rate of 1.3% per year. atect's return on equity is 5.4%, and it has net margins of 3.5%.
Key information
15.0%
Earnings growth rate
14.6%
EPS growth rate
Life Sciences Industry Growth | 32.0% |
Revenue growth rate | 1.3% |
Return on equity | 5.4% |
Net Margin | 3.5% |
Next Earnings Update | 10 May 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How atect makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 3,199 | 113 | 1,122 | 169 |
30 Sep 23 | 3,218 | 164 | 1,076 | 169 |
30 Jun 23 | 3,073 | 180 | 1,034 | 169 |
31 Mar 23 | 2,961 | 158 | 1,025 | 169 |
31 Dec 22 | 2,944 | 147 | 1,001 | 196 |
30 Sep 22 | 2,907 | 156 | 995 | 196 |
30 Jun 22 | 3,005 | 149 | 1,059 | 196 |
31 Mar 22 | 3,086 | 169 | 1,056 | 196 |
31 Dec 21 | 3,116 | 179 | 1,068 | 181 |
30 Sep 21 | 3,123 | 148 | 1,064 | 181 |
30 Jun 21 | 3,024 | 141 | 996 | 181 |
31 Mar 21 | 2,855 | 75 | 982 | 181 |
31 Dec 20 | 2,797 | -1 | 893 | 266 |
30 Sep 20 | 2,787 | 14 | 919 | 266 |
30 Jun 20 | 2,882 | 15 | 982 | 266 |
31 Mar 20 | 2,977 | 38 | 1,007 | 266 |
31 Dec 19 | 2,996 | 79 | 1,054 | 229 |
30 Sep 19 | 3,052 | 94 | 1,034 | 229 |
30 Jun 19 | 3,015 | 124 | 976 | 229 |
31 Mar 19 | 2,955 | 127 | 933 | 229 |
31 Dec 18 | 2,851 | 146 | 951 | 178 |
30 Sep 18 | 2,760 | 131 | 936 | 178 |
30 Jun 18 | 2,713 | 103 | 946 | 178 |
31 Mar 18 | 2,669 | 82 | 952 | 178 |
31 Dec 17 | 2,695 | 50 | 1,133 | 0 |
30 Sep 17 | 2,616 | 63 | 1,104 | 0 |
30 Jun 17 | 2,542 | 72 | 1,062 | 0 |
31 Mar 17 | 2,483 | 51 | 1,033 | 0 |
31 Dec 16 | 2,425 | 31 | 1,005 | 0 |
30 Sep 16 | 2,445 | 47 | 987 | 0 |
30 Jun 16 | 2,446 | 7 | 981 | 0 |
31 Mar 16 | 2,473 | 75 | 967 | 0 |
31 Dec 15 | 2,455 | 122 | 856 | 83 |
30 Sep 15 | 2,443 | 117 | 859 | 83 |
30 Jun 15 | 2,406 | 158 | 838 | 83 |
31 Mar 15 | 2,361 | 125 | 820 | 83 |
31 Dec 14 | 2,351 | 111 | 844 | 63 |
30 Sep 14 | 2,375 | 95 | 832 | 63 |
30 Jun 14 | 2,403 | 98 | 841 | 63 |
31 Mar 14 | 2,500 | 145 | 856 | 63 |
31 Dec 13 | 2,532 | 165 | 887 | 34 |
30 Sep 13 | 2,525 | 231 | 886 | 34 |
30 Jun 13 | 2,520 | 235 | 874 | 34 |
Quality Earnings: 4241 has high quality earnings.
Growing Profit Margin: 4241's current net profit margins (3.5%) are lower than last year (5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 4241's earnings have grown by 15% per year over the past 5 years.
Accelerating Growth: 4241's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 4241 had negative earnings growth (-23.1%) over the past year, making it difficult to compare to the Life Sciences industry average (-19.3%).
Return on Equity
High ROE: 4241's Return on Equity (5.4%) is considered low.